Evidence map›Paper›PMID 25991655›Full record

ArticleThe international journal of neuropsychopharmacology2015

A Methionine-Induced Animal Model of Schizophrenia: Face and Predictive Validity.

Lien Wang, Amal Alachkar, Nayna Sanathara, James D Belluzzi, Zhiwei Wang, Olivier Civelli

Open access · goldAbstract readValidation Study
In one paragraph

Article in The international journal of neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Molecular Landscape of Tourette's Disorder.International journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. [Variations in fecal microbiota of first episode schizophrenia associated with clinical assessment and serum metabolomics].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2022
    Article
  8. Methylome-wide Association Study of Patients with Recent-onset Psychosis.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Protective Effects of Two Halophilic Crude Extracts fromEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. DNA Methylation in Animal Models of Psychosis.Progress in molecular biology and translational science · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lien WangDepartments of Pharmacology (Ms L. Wang, Dr Alachkar, Ms Sanathara, Dr Belluzzi, Dr Z. Wang, and Dr Civelli), Pharmaceutical Sciences (Dr Civelli), and Developmental and Cell Biology (Dr Civelli), School of Medicine, University of California, Irvine.CA.
Amal AlachkarDepartments of Pharmacology (Ms L. Wang, Dr Alachkar, Ms Sanathara, Dr Belluzzi, Dr Z. Wang, and Dr Civelli), Pharmaceutical Sciences (Dr Civelli), and Developmental and Cell Biology (Dr Civelli), School of Medicine, University of California, Irvine.CA.
Nayna SanatharaDepartments of Pharmacology (Ms L. Wang, Dr Alachkar, Ms Sanathara, Dr Belluzzi, Dr Z. Wang, and Dr Civelli), Pharmaceutical Sciences (Dr Civelli), and Developmental and Cell Biology (Dr Civelli), School of Medicine, University of California, Irvine.CA.
James D BelluzziDepartments of Pharmacology (Ms L. Wang, Dr Alachkar, Ms Sanathara, Dr Belluzzi, Dr Z. Wang, and Dr Civelli), Pharmaceutical Sciences (Dr Civelli), and Developmental and Cell Biology (Dr Civelli), School of Medicine, University of California, Irvine.CA.
Zhiwei WangDepartments of Pharmacology (Ms L. Wang, Dr Alachkar, Ms Sanathara, Dr Belluzzi, Dr Z. Wang, and Dr Civelli), Pharmaceutical Sciences (Dr Civelli), and Developmental and Cell Biology (Dr Civelli), School of Medicine, University of California, Irvine.CA.
Olivier CivelliDepartments of Pharmacology (Ms L. Wang, Dr Alachkar, Ms Sanathara, Dr Belluzzi, Dr Z. Wang, and Dr Civelli), Pharmaceutical Sciences (Dr Civelli), and Developmental and Cell Biology (Dr Civelli), School of Medicine, University of California, Irvine.CA. ocivelli@uci.edu.
Defence Research and Development Organisation · IN

Funding

A novel neuropeptide system involved in drug abuseR01DA024746 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI CIVELLI, OLIVIER · 2010 to 2013
$1.5M
NIDA NIH HHS DA024746NIDA NIH HHS R01 DA024746
6 · The paper itself

Abstract

backgroundModulating the methylation process induces broad biochemical changes, some of which may be involved in schizophrenia. Methylation is in particular central to epigenesis, which is also recognized as a factor in the etiology of schizophrenia. Because methionine administration to patients with schizophrenia has been reported to exacerbate their psychotic symptoms and because mice treated with methionine exhibited social deficits and prepulse inhibition impairment, we investigated whether methionine administration could lead to behavioral changes that reflect schizophrenic symptoms in mice.

methodsl-Methionine was administered to mice twice a day for 7 days.

resultsWe found that this treatment induces behavioral responses that reflect the 3 types of schizophrenia-like symptoms (positive, negative, or cognitive deficits) as monitored in a battery of behavioral assays (locomotion, stereotypy, social interaction, forced swimming, prepulse inhibition, novel object recognition, and inhibitory avoidance). Moreover, these responses were differentially reversed by typical haloperidol and atypical clozapine antipsychotics in ways that parallel their effects in schizophrenics.

conclusionWe thus propose the l-methionine treatment as an animal model recapitulating several symptoms of schizophrenia. We have established the face and predictive validity for this model. Our model relies on an essential natural amino acid and on an intervention that is relatively simple and time effective and may offer an additional tool for assessing novel antipsychotics.

Indexed as

Disease Models, AnimalSchizophreniaAnimalsAntipsychotic AgentsAvoidance LearningClozapineDepressionHaloperidolMaleMethionineMiceMotor ActivityPain ThresholdRecognition, PsychologySchizophrenic PsychologySensory GatingAntipsychotic AgentsClozapineHaloperidolMethionineface validitymethioninemouse modelpredictive validitySchizophrenia

Identifiers

PMID25991655
PMCPMC4675974
OpenAlexW2196598555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.